Abstract:Sequencing of Ebola virus (EBOV) genomes during the 2014-2016 epidemic identified several naturally occurring, dominant mutations potentially impacting virulence or tropism. In this study, we characterized EBOV variants carrying one of the following substitutions: A82V in the glycoprotein (GP), R111C in the nucleoprotein (NP), or D759G in the RNA-dependent RNA polymerase (L). Compared with the wild-type (WT) EBOV C07 isolate, NP and L mutants conferred a replication advantage in monkey Vero E6, human A549, and insectivorous bat Tb1.Lu cells, while L mutants displayed a disadvantage in human Huh7 cells. The replication of the GP mutant was significantly delayed in Tb1.Lu cells and similar to that of the WT in other cells. The L mutant was less virulent, as evidenced by increased survival for mice and a significantly delayed time to death for ferrets, but increased lengths of the period of EBOV shedding may have contributed to the prolonged epidemic. Our results show that single substitutions can have observable impacts on EBOV pathogenicity and provide a framework for the study of other mutations. IMPORTANCE During the Ebola virus (EBOV) disease outbreak in West Africa in 2014-2016, it was discovered that several mutations in the virus emerged and became prevalent in the human population. This suggests that these mutations may play a role impacting viral fitness. We investigated three of these previously identified mutations (in the glycoprotein [GP] nucleoprotein [NP], or RNA-dependent RNA polymerase [L]) in cell culture, as well as in mice and ferrets, by generating recombinant viruses (based on an early West African EBOV strain) each carrying one of these mutations. The NP and L mutations appear to decrease virulence, whereas the GP mutation slightly increases virulence but mainly impacts viral tropism. Our results show that these single mutations can impact EBOV virulence in animals and have implications for the rational design of efficacious antiviral therapies against these infections.

Intra-host Dynamics of Ebola Virus During 2014.

Mapping the Clinical Outcomes and Genetic Evolution of Ebola Virus in Sierra Leone.

Intra-host Ebola Viral Adaption During Human Infection

Single-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host Dynamics

Identifying spatiotemporal dynamics of Ebola in Sierra Leone using virus genomes

Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity

Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses

The Lifecycle of the Ebola Virus in Host Cells.

Genetic Diversity and Evolutionary Dynamics of Ebola Virus in Sierra Leone

Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity.

Features of Ebola Virus Disease at the Late Outbreak Stage in Sierra Leone: Clinical, Virological, Immunological, and Evolutionary Analyses.

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

Epidemiological and evolutionary analysis of the 2014 Ebola virus outbreak

Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone.

Modeling the transmission dynamics of Ebola virus disease in Liberia.

Ebolaviruscomparative Genomics

The 2014 Ebola Virus Outbreak in West Africa Highlights No Evidence of Rapid Evolution or Adaptation to Humans

Virus genomes reveal factors that spread and sustained the Ebola epidemic

Lineage classification and selective site identification of Orthoebolavirus zairense

Interplay Among Constitutes of Ebola Virus: Nucleoprotein, Polymerase L, Viral Proteins

Serological Investigation of Laboratory-Confirmed and Suspected Ebola Virus Disease Patients During the Late Phase of the Ebola Outbreak in Sierra Leone